Group One Trading, L.P. Arbutus Biopharma Corp Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 59,559 shares of ABUS stock, worth $198,331. This represents 0.01% of its overall portfolio holdings.

Number of Shares

59,559

Previous 26,191 127.4%

Holding current value

$198,331

Previous $80,000 186.25%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.12 - $4.56 $104,108 - $152,158	33,368 Added 127.4%	59,559 $229,000
Q2 2024 Aug 14, 2024	SELL	$2.52 - $3.63 $100,235 - $144,386	-39,776 Reduced 60.3%	26,191 $80,000
Q1 2024 May 10, 2024	BUY	$2.26 - $2.92 $132,560 - $171,272	58,655 Added 802.17%	65,967 $170,000
Q4 2023 Feb 14, 2024	BUY	$1.69 - $2.54 $12,357 - $18,572	7,312 New	7,312 $18,000
Q3 2022 Nov 09, 2022	SELL	$1.88 - $2.88 $14,519 - $22,242	-7,723 Reduced 55.82%	6,112 $12,000
Q2 2022 Aug 11, 2022	SELL	$1.98 - $3.17 $340,453 - $545,068	-171,946 Reduced 92.55%	13,835 $37,000
Q1 2022 May 12, 2022	SELL	$2.42 - $3.98 $418,033 - $687,509	-172,741 Reduced 48.18%	185,781 $554,000
Q4 2021 Feb 11, 2022	BUY	$3.11 - $4.61 $330,583 - $490,029	106,297 Added 42.14%	358,522 $1.4 Million
Q3 2021 Nov 12, 2021	BUY	$2.65 - $4.62 $475,394 - $828,800	179,394 Added 246.32%	252,225 $1.08 Million
Q2 2021 Aug 10, 2021	SELL	$2.5 - $3.51 $129,395 - $181,670	-51,758 Reduced 41.54%	72,831 $221,000
Q1 2021 May 12, 2021	SELL	$3.14 - $4.84 $640,848 - $987,805	-204,092 Reduced 62.09%	124,589 $415,000
Q4 2020 Feb 10, 2021	BUY	$2.76 - $4.97 $704,131 - $1.27 Million	255,120 Added 346.81%	328,681 $1.17 Million
Q3 2020 Nov 12, 2020	BUY	$1.75 - $6.2 $128,731 - $456,078	73,561 New	73,561 $230,000
Q2 2020 Aug 13, 2020	SELL	$0.91 - $2.36 $4,983 - $12,923	-5,476 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.01 - $3.42 $5,530 - $18,727	5,476 New	5,476 $6,000
Q4 2019 Feb 10, 2020	SELL	$0.87 - $2.89 $2,731 - $9,074	-3,140 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$1.34 - $2.4 $1,878 - $3,364	-1,402 Reduced 30.87%	3,140 $5,000
Q2 2019 Aug 09, 2019	BUY	$1.46 - $4.44 $6,631 - $20,166	4,542 New	4,542 $9,000
Q1 2019 May 13, 2019	SELL	$3.41 - $4.57 $6,073 - $8,139	-1,781 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$3.5 - $9.66 $6,233 - $17,204	1,781 New	1,781 $7,000
Q4 2017 Feb 09, 2018	SELL	$4.45 - $7.7 $88,243 - $152,691	-19,830 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$3.4 - $7.0 $21,355 - $43,967	6,281 Added 46.36%	19,830 $123,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,549	13,549 $49,000

Others Institutions Holding ABUS

# of Institutions

157

Shares Held

99.6M

Call Options Held

2.31M

Put Options Held

525K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $499M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Arbutus Biopharma Corp Transaction History